ZORDAN, M.; FIORIO, E.; MAFFEIS, V.; MAFFICINI, A.; QUERZOLI, G.; BARIOGLIO, B.; BIONDANI, P.; BRUNELLI, M.; INVENTO, A.; PELLINI, F.; LUCHINI, C.; SCARPA, A.; NOTTEGAR, A. HER2-positive neuroendocrine breast carcinoma: a case study uncovers CCND1, FGF19, and IGF1R amplifications as new molecular drivers. Pathologica - Journal of the Italian Society of Anatomic Pathology and Diagnostic Cytopathology, [S. l.], v. 117, n. 4, 2025. DOI: 10.32074/1591-951X-N981. Disponível em: https://www.pathologica.it/article/view/981. Acesso em: 18 oct. 2025.